You mean this low-volume walk-down? Typical. But rest assured I am sure Instys who have been buying are still holding their shares. This is 80% retail traders walking this down and IMO doesn't reflect any of the science being 2-73. I watched the same thing happen to NK during the run to $15, only to be walked down to sub-$9...3 months later the stock was at $45 and change. Poor suckers that sold too early. Its biotech....manipulation, FUD and the typical opinion based narratives are all part of the game.
As far as CEO Missling "mis-calcs": Personally I'm pretty happy with his performance to be truthful. Minimal dilutional and running how many trials now? He has navigated a virtual minefield and has us on the cusp of some big stuff. Enough cash for 3 years and partnering with non-profits in all the correct places. To say otherwise is not being truthful. This ticker was trading at $3 this time last year. Not too bad of a return, even if you didn't sell in the $20s like some of us.
As far as "plenty of time to get back in": Famous last words. I personally think many here will be caught of guard by some sort of breaking news that was unexpected. There is some much going on so I wont even begin to speculate which indication will provide the news, but 100% think something large is about to happen. "plenty of time" is plenty until its isnt anymore. Whether its stocks or fighting fires, the clock is always ticking, and surprises can blind-side even the most savvy and experienced.
-Fireman